COHANCE
Cohance Lifesciences Limited engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally. The company offers small molecule APIs, advanced intermediates, and starting materials; antibody drug conjugates; … Read more
COHANCE (COHANCE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2023: 0.013x
Based on the latest financial reports, COHANCE (COHANCE) has a cash flow conversion efficiency ratio of 0.013x as of December 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹255.04 Million) by net assets (₹19.81 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
COHANCE - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how COHANCE's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
COHANCE Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of COHANCE ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tianjin Port Development Holdings Limited
PINK:TJIPY
|
0.023x |
|
Compania Nationala de Transport al Energiei Electrice Transelectrica SA
RO:TEL
|
0.073x |
|
Stabilus S.A
PINK:SIUAF
|
0.048x |
|
Trican Well Service Ltd.
PINK:TOLWF
|
0.127x |
|
Vijaya Diagnostic Centre Limited
NSE:VIJAYA
|
0.034x |
|
INVENTIVA ADS/1 O.N.
F:6IVA
|
N/A |
|
Delta Galil Industries Ltd
OTCGREY:DELTF
|
0.046x |
|
Wuxi Online Offline Communication Information Technology Co. Ltd.
SHE:300959
|
N/A |
Annual Cash Flow Conversion Efficiency for COHANCE (2019–2025)
The table below shows the annual cash flow conversion efficiency of COHANCE from 2019 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹18.41 Billion | ₹2.88 Billion | 0.157x | -10.44% |
| 2024-03-31 | ₹20.51 Billion | ₹3.58 Billion | 0.175x | -32.73% |
| 2023-03-31 | ₹17.35 Billion | ₹4.51 Billion | 0.260x | +20.26% |
| 2022-03-31 | ₹15.27 Billion | ₹3.30 Billion | 0.216x | -33.46% |
| 2021-03-31 | ₹11.81 Billion | ₹3.83 Billion | 0.325x | -34.05% |
| 2020-03-31 | ₹8.45 Billion | ₹4.16 Billion | 0.492x | +476.64% |
| 2019-03-31 | ₹5.90 Billion | ₹504.05 Million | 0.085x | -- |